In the crowded landscape of medical device startups, InterscopeMed is playing a different game entirely. While competitors chase hype cycles, this 20-person team has built a $5M revenue business on a single, disruptive device: the EndoRotor®. This isn't just another medical equipment company—it's a surgical precision tool that solves one of gastroenterology's most persistent headaches.

"They're not building a platform—they're building a surgical necessity. The EndoRotor doesn't just compete; it redefines the standard of care for endoscopic necrosectomy."

The leadership team reveals their clinical-first DNA. CEO Jeffery Ryan leads a crew that includes a Global Director of Clinical Affairs (Alexis James) and a Quality Operations Manager (Elsa Figueroa). This isn't a tech startup with medical aspirations—it's a medical company that understands regulatory pathways, clinical validation, and the long sales cycles inherent to surgical innovation. The VP Sales, USA (Ed Wierzbicki) indicates a focused domestic strategy before international expansion.

• The EndoRotor® solves incomplete resection—a major pain point in gastroenterology
• 20-person team with deep clinical expertise (not just engineering)
• $5M revenue suggests early commercial traction without VC hype
• Deliberate obscurity: low web traffic but high clinical credibility
• Squarespace + jQuery tech stack indicates pragmatic, cost-effective digital presence